A Randomized Controlled Clinical Trial To Evaluate Efficacy Of Shallakyadi Taila Pichu And Nystatin Pessary In The Management Of Vipluta Yonivyapad With Special Reference Of Pruritus Vulvae
概览
- 阶段
- 2/3 期
- 状态
- 尚未招募
- 发起方
- Vijaylaxmi Munshilal Maurya
- 入组人数
- 60
- 试验地点
- 1
- 主要终点
- The primary outcome focuses on the clinical efficacy of Shallakyadi Taila Pichu versus Nystatin pessary in managing Vipluta Yonivyapad, with special reference to pruritus vulvae. It will be assessed based on symptomatic relief (Yonikandu, Yonistrava, Yonivedana, Dyspareunia, Dysuria). Assessment will occur at baseline, during treatment, post-treatment, and follow-ups.
概览
简要总结
This study is a randomized controlled clinical trial to study the efficacy of shallakyadi taila pichu dharan in yoni and nystatin pessary per vaginum in the management of vipluta yonivyapada w.s.r to pruritus vulvae. Study will be carried out in opd of prasuti tantra and stree roga department of Late kedari redekar ayurvedic hospital,Gadhinglaj. The observation would be drawn on the basisi of symptoms after treatment given.
研究设计
- 研究类型
- Interventional
- 分配方式
- Coin toss, Lottery, toss of dice, shuffling cards etc
- 盲法
- None
入排标准
- 年龄范围
- 20.00 Year(s) 至 45.00 Year(s)（—）
- 性别
- Female
入选标准
- •Patient having sign and symptoms of vipluta yonivyapada having symtooms like yoni kandu,aatiratipriya, nitya yonivedana,such patient will be randomly selected from prasuti tantra stree roga opd of late kedari redekar ayurvedic hospital.
排除标准
- •unmarried,pregnant and lactational, H/O-DM, Patient associated with Genital TB infection,HIV,HBsAG,VDRL postive, Patient with benign and malignant tumor of buterus and cervix, patient who need surgical intervention in cases like pelvis abscess, Tubo-ovarian mass.
结局指标
主要结局
The primary outcome focuses on the clinical efficacy of Shallakyadi Taila Pichu versus Nystatin pessary in managing Vipluta Yonivyapad, with special reference to pruritus vulvae. It will be assessed based on symptomatic relief (Yonikandu, Yonistrava, Yonivedana, Dyspareunia, Dysuria). Assessment will occur at baseline, during treatment, post-treatment, and follow-ups.
时间窗: 15 days
次要结局
未报告次要终点
研究者
VIJAYLAXMI MAUNSHILAL MAURYA
Late Kedari Redekar Ayurvedic Mahavidyalaya